Disease burden of age-related macular degeneration in China from 1990 to 2019: findings from the global burden of disease study

por Zhang, Yichi, Chen, Aiming, Zou, Minjie, Yang, Zhenlan, Zheng, Danying, Fan, Min, Jin, Guangming
Publicado 2021

Prevalence of visual impairment among older Chinese population: A systematic review and meta-analysis

por Zou, Minjie, Guo, Dongwei, Chen, Aiming, Young, Charlotte Aimee, Li, Yi, Zheng, Danying, Jin, Guangming
Publicado 2021

Prevalence and time trends of refractive error in Chinese children: A systematic review and meta-analysis

por Tang, Yi, Chen, Aiming, Zou, Minjie, Liu, Zhenzhen, Young, Charlotte Aimee, Zheng, Danying, Jin, Guangming
Publicado 2021

Disease Burden of Glaucoma in China: Findings from the Global Burden of Disease 2019 Study

por Sun, Yi, Chen, Aiming, Zou, Minjie, Liu, Zhenzhen, Young, Charlotte Aimee, Zheng, Danying, Jin, Guangming
Publicado 2022

Disease Burden of Chronic Kidney Disease Due to Hypertension From 1990 to 2019: A Global Analysis

por Chen, Aiming, Zou, Minjie, Young, Charlotte Aimee, Zhu, Weiping, Chiu, Herng-Chia, Jin, Guangming, Tian, Lin
Publicado 2021

Comprehensive safety profile evaluation of bivalirudin in Chinese ST-segment elevation myocardial infarction patients receiving percutaneous coronary intervention: a prospective, m...

por Zheng, Haijun, Wang, Zhonghua, Li, Qi, Zhao, Yingxin, Liu, Yin, Chen, Aiming, Deng, Jianping, Su, Guohai
Publicado 2022

Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017

por Sun, Yi, Chen, Aiming, Zou, Minjie, Zhang, Yichi, Jin, Ling, Li, Yi, Zheng, Danying, Jin, Guangming, Congdon, Nathan
Publicado 2022

Quantitative Analysis of a Weak Correlation between Complicated Data on the Basis of Principal Component Analysis

por Pang, Tao, Zhang, Haitao, Wen, Liliang, Tang, Jun, Zhou, Bing, Yang, Qianxu, Li, Yong, Wang, Jiajun, Chen, Aiming, Zeng, Zhongda
Publicado 2021

IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin

por Pang, Nengzhi, Shi, Jingxuan, Qin, Le, Chen, Aiming, Tang, Yuou, Yang, Hainan, Huang, Yufeng, Wu, Qingde, Li, Xufeng, He, Bingjia, Li, Tianheng, Liang, Baoxia, Zhang, Jinglin, Cao, Bihui, Liu, Manting, Feng, Yunfei, Ye, Xiaodie, Chen, Xiaopei, Wang, Lu, Tian, Yu, Li, Hao, Li, Junping, Hu, Hong, He, Jingping, Hu, Yuling, Zhi, Cheng, Tang, Zhaoyang, Gong, Yibo, Xu, Fangting, Xu, Linfeng, Fan, Weijun, Zhao, Ming, Chen, Deji, Lian, Hui, Yang, Lili, Li, Peng, Zhang, Zhenfeng
Publicado 2021